Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
TUZISTRA XR (CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
TUZISTRA XR
NDA
Get alerts
CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX | N207768 | TRIS PHARMA INC
1 strength
2 unique patents
0 unique exclusivities
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Approvals
Label
Products
Patent Timeline
2 unique patents by expiration date
Expiring < 1yr (1)
Active (1)
Today
2027
2028
2029
Today
8062667
Mar. 29, 2029
8790700
Mar. 15, 2027
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — EQ 2.8MG BASE/5ML;EQ 14.7MG BASE/5ML
RLD
2 patents
0 exclusivities
▴
SUSPENSION, EXTENDED RELEASE;ORAL | Approved: Apr 30, 2015
Patents (2)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
8062667
Mar 29, 2029
—
—
Yes
—
—
8790700
Mar 15, 2027
—
—
Yes
—
—